Synthesis and analgesic activity of a series of new azaalkane bis-guanidinium and bis(2-aminoimidazolinium) compounds

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 7, 2003, Pages 1283-1291

  Dardonville, Christophe ^a,d   Rozas, Isabel ^b   Goya, Pilar ^a   Girón, Rocío ^c   Goicoechea, Carlos ^c   Martín, Ma Isabel ^c  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMINE; ANALGESIC AGENT; GUANIDINE DERIVATIVE; IMIDAZOLINIUM; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG SYNTHESIS; HOT PLATE TEST; IN VIVO STUDY; MOUSE; NONHUMAN; WRITHING TEST;

EID: 0037375827     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00637-5     Document Type: Article

References (21)

1. http://www.efic.org/about_pain.htm#costs.
2. Waddell G. Spine. 21:1996;2820.
3. Williams M., Kowaluk E.A., Arneric S.P. J. Med. Chem. 42:1999;1481.
4. Dardonville C., Rozas I., Alkorta I. J. Mol. Graphics Mod. 16:1999;150.
5. Villarroya M., Gandía L., López M.G., García A.G., Cueto S., García-Navio J.L., Alvarez-Builla J. Bioorg. Med. Chem. 8:1996;1177.
6. Short J.H., Biermacher U., Dunnigan D.A., Leth T.D. J. Med. Chem. 6:1963;275.
7. 2-imidazoline binding site in human brain tissues: Dardonville C., Rozas I., Callado L.F., Meana J. Bioorg. Med. Chem. 10:2002;1525.
8. Murahashi S.-I., Naota T., Nakajima N. Chem. Lett. 1987;879.
9. Borch R.F., Bernstein M.D., Durst H. J. Am. Chem. Soc. 93:1971;2897.
10. Ariga K., Anslyn E.V. J. Org. Chem. 57:1992;417.
11. (a) Collier H.O., Dinneen L.C., Johnson C.A., Schneider C. Br. J. Pharmac. Chemother. 32:1968;295
12. (b) Martínez V., Thakur S., Mogil J.S., Tache Y., Mayer E.A. Pain. 81:1999;179.
13. MDS Pharma Services, 11804 North Creek PKwy. S. Bothell, WA 98011-8890, USA.
14. Martín M.I., Goicoechea C., Ormazábal M.J., Alfaro M.J. Br. J. Pharmacol. 119:1996;804.
15. (a) Capasso A. Neuropharmacology. 38:1999;871
16. (b) Schmidt R., Menard D., Mrestani-Klaus C., Chung N.N., Lemieux C., Schiller P.W. Peptides. 18:1997;1615
17. (c) Menzies J.R., Paterson S.J., Duwiejua M., Corbett A.D. Eur. J. Pharmacol. 350:1998;101
18. (d) Saito T., Aoki F., Hirai H., Inagaki T., Matsunaga Y., Sakakibara T., Sakemi S., Suzuki Y., Watanabe S., Suga O., Sujaku T., Smogowicz A.A., Truesdell S.J., Wong J.W., Nagahisa A., Kojima Y., Kojima N. J. Antibiot. (Tokyo). 51:1998;983.
19. Goicoechea C., Ormazábal M.J., Alfaro M.J., Martín M.I. Neurosci. Lett. 262:1999;25.
20. Martín M.I., Goicoechea C., Colado M.I., Alfaro M.J. Eur. J. Pharmacol. 224:1992;77.
21. Ambache N. J. Physiol. 127:1954;53.